Multi-strain phage-induced clearance of Pseudomonas aeruginosa
ORAL
Abstract
Antibiotic resistant bacteria are a serious global health threat. As a
result, phages – viruses that exclusively infect and
lyse bacteria – are increasingly considered as a therapeutic
alternative to treat bacterial infections. But, bacteria can develop
resistance against phages during treatment leading to adverse clinical
outcomes. Mixtures of multiple phages (i.e., 'cocktails') have been
proposed as a means to minimize the chance that the emergence of a
phage-resistant bacterial mutant leads to therapeutic failure. Here, we
address quantitatively how to design a phage cocktail efficient against
Pseudomonas aeruginosa infections. We study the efficacy of a cocktail
composed of two phages that bind to different bacterial receptors, via a
combination of vitro experiments and nonlinear dynamics models. We show
that the phage cocktail can control the bacterial population and utilize
model-data comparisons to shed light on physiological mechanisms
underlying emergent population dynamics. We leverage these findings to
analyze a theoretical model of in vivo infection dynamics, where
therapeutic phage and the innate immune system can work synergistically to
prevent infection. We quantify the therapy outcome in a single- or
double-phage treatment as a function of phage traits and immune strength.
result, phages – viruses that exclusively infect and
lyse bacteria – are increasingly considered as a therapeutic
alternative to treat bacterial infections. But, bacteria can develop
resistance against phages during treatment leading to adverse clinical
outcomes. Mixtures of multiple phages (i.e., 'cocktails') have been
proposed as a means to minimize the chance that the emergence of a
phage-resistant bacterial mutant leads to therapeutic failure. Here, we
address quantitatively how to design a phage cocktail efficient against
Pseudomonas aeruginosa infections. We study the efficacy of a cocktail
composed of two phages that bind to different bacterial receptors, via a
combination of vitro experiments and nonlinear dynamics models. We show
that the phage cocktail can control the bacterial population and utilize
model-data comparisons to shed light on physiological mechanisms
underlying emergent population dynamics. We leverage these findings to
analyze a theoretical model of in vivo infection dynamics, where
therapeutic phage and the innate immune system can work synergistically to
prevent infection. We quantify the therapy outcome in a single- or
double-phage treatment as a function of phage traits and immune strength.
*This work was supported by grants from the National Institutes of Health (1R01AI46592-01 to JSW and LD), from the Conseil Régional Ile de France Chaire Blaise Pascal (to JSW) and from Agence Nationale de la Recherche (ANR-19-AMRB-0002 to LD)
–
Presenters
-
Jacopo Marchi
- Georgia Institute of Technology